Literature DB >> 12470523

New developments in gonadotrophin pharmacology.

Keith Gordon1.   

Abstract

This article reviews the past, present, and future of gonadotrophin therapy, including purification of gonadotrophins from animal or human urine sources and production of gonadotrophins through recombinant technology. With the advent of recombinant DNA methodologies combined with site-directed mutagenesis, a variety of structural modifications becomes possible.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12470523     DOI： 10.1016/s1472-6483(10)61829-9

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN： 1472-6483            Impact factor:   3.828


  3 in total

1.  Recombinant follitropin alfa/lutropin alfa in fertility treatment.

Authors:  Ahmed Gibreel; Siladitya Bhattacharya
Journal:  Biologics       Date:  2010-02-04

2.  Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women.

Authors:  Marleen Nahuis; Fulco van der Veen; Jur Oosterhuis; Ben Willem Mol; Peter Hompes; Madelon van Wely
Journal:  Int J Womens Health       Date:  2010-08-09

3.  A prospective, randomised, controlled clinical study on the assessment of tolerability and of clinical efficacy of Merional (hMG-IBSA) administered subcutaneously versus Merional administered intramuscularly in women undergoing multifollicular ovarian stimulation in an ART programme (IVF).

Authors:  Carlo Alviggi; Alberto Revelli; Paola Anserini; Antonio Ranieri; Luigi Fedele; Ida Strina; Marco Massobrio; Nicola Ragni; Giuseppe De Placido
Journal:  Reprod Biol Endocrinol       Date:  2007-12-04       Impact factor: 5.211
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.